| Literature DB >> 26114893 |
Els K Vanhoutte1, Thomas H P Draak2, Kenneth C Gorson3, Sonja I van Nes4, Janneke G J Hoeijmakers2, W-Ludo Van der Pol5, Nicolette C Notermans5, Richard A Lewis6, Eduardo Nobile-Orazio7, Jean-Marc Léger8, Peter Y K Van den Bergh9, Giuseppe Lauria10, Vera Bril11, Hans Katzberg11, Michael P T Lunn12, Jean Pouget13, Anneke J van der Kooi14, Angelika F Hahn15, Pieter A van Doorn4, David R Cornblath16, Leonard H van den Berg5, Catharina G Faber2, Ingemar S J Merkies2,17.
Abstract
This study aimed to 'define responder' through the concept of minimum clinically important differences using the individually obtained standard errors (MCID-SE) and a heuristic 'external criterion' responsiveness method in patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). One hundred and fourteen newly diagnosed or relapsing patients (GBS: 55, CIDP: 59) were serially examined (1-year follow-up). The inflammatory Rasch-built overall disability scale (I-RODS), Rasch-transformed MRC sum score (RT-MRC), and Rasch-transformed modified-INCAT-sensory scale (RT-mISS) were assessed. Being-a-responder was defined as having a MCID-SE cut-off ≥1.96. Also, the correlations between patients' scores on each scale and the EuroQoL health-status 'thermometer' (external criterion) were determined (higher correlation indicated better responsiveness). In both diseases, the SEs showed a characteristic 'U'-shaped dynamic pattern across each scales' continuum. The number of patients showing a meaningful change were higher for the I-RODS > RT-MRC > RT-mISS and were in GBS higher than CIDP patients. The MCID-SE concept using Rasch-transformed data demonstrated an individual pattern of 'being-a-responder' in patients with immune-mediated neuropathies, and the findings were validated by the external criterion responsiveness method. The I-RODS showed greater responsiveness compared with the MRC and INCAT-sensory scales, and its use is therefore recommended in future trials in GBS and CIDP.Entities:
Keywords: Rasch; immune-mediated neuropathies; minimum clinically important difference; outcome measure
Mesh:
Substances:
Year: 2015 PMID: 26114893 DOI: 10.1111/jns.12118
Source DB: PubMed Journal: J Peripher Nerv Syst ISSN: 1085-9489 Impact factor: 3.494